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Abstract
In cluster randomised trials, randomisation increases internal study validity. If enough clusters are randomised, an
unadjusted analysis should be unbiased. If a smaller number of clusters are included, stratified or matched
randomisation can increase comparability between trial arms. In addition, an adjusted analysis may be required;
nevertheless, randomisation removes the possibility for systematically biased allocation and increases transparency.
In stepped wedge trials, clusters are randomised to receive an intervention at different start times (‘steps’), and all
clusters eventually receive it. In a recent study protocol for a ‘modified stepped wedge trial’, the investigators
considered randomisation of the clusters (hospital wards), but decided against it for ethical and logistical reasons,
and under the assumption that it would not add much to the rigour of the evaluation. We show that the benefits
of randomisation for cluster randomised trials also apply to stepped wedge trials. The biggest additional issue for
stepped wedge trials in relation to parallel cluster randomised trials is the need to control for secular trends in the
outcome. Analysis of stepped wedge trials can in theory be based on ‘horizontal’ or ‘vertical’ comparisons.
Horizontal comparisons are based on measurements taken before and after the intervention is introduced in each
cluster, and are unbiased if there are no secular trends. Vertical comparisons are based on outcome measurements
from clusters that have switched to the intervention condition and those from clusters that have yet to switch, and
are unbiased under randomisation since at any time point, which clusters are in intervention and control conditions
will have been determined at random. Secular outcome trends are a possibility in many settings. Many stepped
wedge trials are analysed with a mixed model, including a random effect for cluster and fixed effects for time
period to account for secular trends, thereby combining both vertical and horizontal comparisons of intervention
and control clusters. The importance of randomisation in a stepped wedge trial is that the effects of time can be
estimated from the data, and bias from secular trends that would otherwise arise can be controlled for, provided
the trends are correctly specified in the model.
Background
In stepped wedge trials, clusters are randomised to receive
an intervention at different start times (‘steps’), and all clus-
ters eventually receive it. The popularity of the design is
increasing and debate about their use, design and analysis
is ongoing [1–3]. This issue of Trials features a protocol for
a study described as a ‘modified stepped wedge’ [4]. DiDio-
dato et al. investigate whether an antimicrobial stewardship
intervention involving prospective chart audit and feedback
could reduce the length of stay in hospital for patients
admitted with community-acquired pneumonia [4]. They
plan to introduce the intervention in four hospital wards
sequentially, but without randomising the order of intro-
duction. Importantly, the authors state that they considered
randomisation but decided against it for ethical and logis-
tical reasons, and under the assumption that it would not
add much to the rigour of the evaluation. In this commen-
tary we examine the value of randomisation in stepped
wedge trials, provide a brief critical appraisal of DiDiodato
et al.’s argument concerning the (lack of) value of random-
isation in their own study, and close with a summary of
arguments in favour of randomisation in stepped wedge
trials.
Main Text
Why is randomisation useful in stepped wedge trials?
Randomisation brings several important benefits to
cluster randomised controlled trials. Most importantly,
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randomisation increases the internal validity of the
study. Analyses of cluster randomised controlled trials
generally compare outcomes between intervention and
control groups after some post-randomisation follow-up
period. If enough clusters are randomised, an unadjusted
comparison should be unbiased. In some cases, especially
in cluster randomised controlled trials with relatively few
clusters, adjustment for potentially imbalanced covariates
is included in the primary analysis [5]. Cluster randomised
controlled trials can also make use of stratified or restricted
randomisation to create more comparable trial arms. Fi-
nally, randomisation can help to increase the transparency
and perceived fairness of allocation. All of these features are
also valuable in stepped wedge trials.
The biggest additional issue for stepped wedge trials in
relation to parallel cluster randomised trials is the need to
control for secular trends in the outcome of interest. Ana-
lysis of stepped wedge trials can in theory be based on
‘horizontal’ or ‘vertical’ comparisons or, as is most common
in practice, a mixture of the two. In their simplest form
horizontal comparisons are based on measurements taken
before and after the intervention is introduced in each clus-
ter. By contrast, vertical comparisons are based on outcome
measurements from clusters that have switched to the
intervention condition and those from clusters that have
yet to switch, within each of several time intervals which
may correspond to the steps of the design.
Horizontal, or before-after, comparisons are unbiased
if there are no secular trends. However, secular outcome
trends are a possibility in many settings. A key import-
ance of randomisation is to allow the estimation of an
unbiased intervention effect even when there are secular
trends. Within a stepped wedge trial, vertical compari-
sons are unbiased under randomisation since at any time
point, which clusters are in the intervention and control
conditions will have been determined at random. Within
a stepped wedge trial randomisation also allows secular
trends to be estimated from the data. If, conversely, clus-
ters are allocated to groups to receive the intervention at
certain times in a systematic way, such as clusters likely
to have poor outcomes receive intervention first, then
secular trends cannot generally be distinguished from
the effects of this allocation mechanism.
In practice, most stepped wedge trials are analysed using
a mixed approach that uses all the data in a single analysis
stage, combining both vertical and horizontal comparisons
of intervention and control clusters [6]. For example a
mixed model may be fitted, including a random effect for
each cluster and fixed effects for time period to account for
secular trends. The importance of randomisation is that
these effects of time can be estimated from the data, and
hence bias from secular trends that would otherwise arise
can be controlled for, at least provided the trends are cor-
rectly specified in the model. We have argued in favour of
careful modelling of time trends, and cross-checking results
from mixed approaches with estimates from vertical ap-
proaches that do not require the form of time trends to be
specified [6, 7].
What would DiDiodato et al. have gained from
randomisation?
The study by DiDiodato et al. involves introducing an
antimicrobial stewardship intervention in a non-random
sequential manner to four hospital wards (clusters), to see
whether it will reduce pneumonia patients’ length of stay
in hospital. The main argument that the authors provide
for the lack of benefit from randomisation of wards is that
patients are allocated to these in a quasi-random fashion,
based on bed availability. Furthermore, the hospitalists
that manage patients work across all four wards. Though
not stated explicitly, the authors’ argument suggests that
wards are thought to be of little relevance to outcomes in
the trial, and the sample size calculation ignores this level
of clustering. If this were the case, rather than thinking of
the study as including a cluster-level allocation mechan-
ism, the study could rather be conceptualised as incorpor-
ating an individually quasi-randomised allocation, with an
allocation ratio that varies over time from favouring con-
trol to later favouring intervention. If there are no ‘ward
effects’ then the non-random ordering of the time at
which the intervention is introduced would not present a
risk of bias. However, the authors go on to propose an
analysis that does incorporate fixed effects of wards, and
of time from the start of the study, so it seems that both
ward effects and secular trends are considered possible.
The authors obviously have excellent knowledge of
the trial setting, but it seems plausible that the system-
atic allocation order of wards (by expected number of
pneumonia patients) may prevent the unbiased
estimation of any secular trends affecting all wards in
the proposed analysis, and consequently the interven-
tion effect may also be biased. This bias might have
been avoided by randomising the wards, although a
further issue in this trial is that the number of wards
is very small. In the current design, bias in the inter-
vention effect may still arise from secular trends, even
if it is the case that the individual patient allocation to
wards by hospitalists is indeed conducted in a fashion
that mimics randomisation. In relation to this last point,
however, we are additionally concerned that if the interven-
tion is indeed successful in reducing length of hospital stay
in the first cluster allocated, this has the potential to influ-
ence the subsequent allocation of patients to wards, since it
is bed availability that is cited as the main quasi-random
factor determining this allocation.
In our view, the study by DiDiodato et al. is not usefully
classified as a modified stepped wedge trial, but rather as a
form of before and after cross-over study conducted in four
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hospital wards. As such, its analysis raises the validity ques-
tion presented by all before and after studies: could there
be secular trends due to things influencing outcomes over
the study period of 24 months other than the intervention?
This seems plausible, casting doubts on the robustness of
this design. In presenting their findings the authors will
need to make a strong case against the potential presence
of such effects.
Conclusion
In stepped wedge trials, randomisation allows an unbiased
analysis, subject to taking due care in appropriately specify-
ing time-trends in the analysis. The DiDiodato et al. study
protocol described in this issue of Trials is perhaps best
conceptualised as a multi-ward, before-after study rather
than a modified stepped wedge trial. More generally, the
comparison between a non-randomised stepped wedge
trial and a randomised stepped wedge trial is in essence
the same as between any non-randomised allocation
design and a cluster randomised controlled trial: the
non-randomised design may give an unbiased answer,
but it is difficult to know this. We therefore argue for
randomisation in stepped wedge trials whenever it is
logistically feasible.
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